Search for: "SANDOZ, INC."
Results 321 - 340
of 679
Sort by Relevance
|
Sort by Date
22 Jul 2014, 5:14 am
This history is significantly different from the Teva Sandoz matter. [read post]
10 Jul 2014, 6:41 am
The recent issue of Environmental Health Perspectives contains several interesting articles on scientific methodology of interest to lawyers who litigate claimed health effects.[1] The issue also contains a commentary that argues for greater transparency in science and science policy, which should be a good thing, but yet the commentary has the potential to obscure and confuse. [read post]
30 Jun 2014, 9:59 am
Sandoz. [read post]
25 Jun 2014, 9:24 am
Sandoz. [read post]
23 Jun 2014, 12:57 pm
” Matrixx Initiatives, Inc. v. [read post]
13 Jun 2014, 6:00 am
Sandoz, Inc., No. 13-854. [read post]
12 Jun 2014, 8:48 pm
Sandoz, Inc., 678 F.3d 1280, 1293 (Fed. [read post]
10 Jun 2014, 5:25 pm
ApotexApotex Inc., Apotex Corp., Sandoz, Inc., Hit-TechPharmacal Co., Inc., Actavis, Inc., Watson Laboratories,Inc., and Watson Pharma, Inc. [read post]
15 May 2014, 9:36 am
Sandoz Pharms. [read post]
29 Apr 2014, 1:39 pm
Sandoz, Inc., No. 13-854 (U.S. [read post]
23 Apr 2014, 8:50 am
Sandoz, Inc., 13-854 (granted at the March 28 Conference, relisted twice); Jennings v. [read post]
22 Apr 2014, 6:22 am
Sandoz, Inc. [read post]
21 Apr 2014, 8:03 am
Sandoz Inc. et al., case number 13-854, in the U.S. [read post]
19 Apr 2014, 8:50 am
On Good Friday, April 18, 2014, Chief Justice Roberts, denied Teva a request for a stay in the Copaxone case, noting that he was not convinced Teva had shown the "likelihood of irreparable harm" if the application was denied, because if Teva wins the Supreme Court case it can seek damages from the generic companies for past infringement on its patents.In this case, Teva, a known generic manufacturer, is in the role of proprietary drug maker, fighting the generic arm of a proprietary company… [read post]
14 Apr 2014, 3:51 pm
The generic firms — Sandoz Inc., Momenta Pharmaceuticals, Inc., Mylan Pharmaceuticals, Inc., and Natco Pharma Ltd. [read post]
14 Apr 2014, 7:15 am
Sandoz, Inc., 3-12-cv-01617 (NJD April 10, 2014, Order) (Sheridan, J.) [read post]
11 Apr 2014, 9:42 pm
ACI faculty will help attendees: • Understand the battles over naming and substitution on the federal and state levels and exploring the implications on competition including the FTC's current perspective; • Analyzing the arguments in the first BPCIA case, Sandoz Inc. v. [read post]
9 Apr 2014, 9:59 pm
Sandoz, you haven't been paying attention). [read post]
9 Apr 2014, 7:03 am
Sandoz, Inc., 3-12-cv-01617 (NJD March 31, 2014, Order) (Sheridan, J.) [read post]
4 Apr 2014, 12:00 pm
Sandoz Inc. concerns Teva’s Copaxone drug used to treat multiple sclerosis. [read post]
